Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Altisource Announces Third Quarter 2026 Financial Results
-
Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz
-
LanzaTech Announces Date for Third Quarter 2026 Earnings Release and Conference Call
-
Microchip Brings EtherCAT® and TSN Networking Solutions to its Power-Efficient PolarFire® FPGA Platform
-
CCC Intelligent Solutions Holdings Inc. Announces Third Quarter 2026 Financial Results
-
Bunzl Canada Brings Free Home Cleaning to Cancer Patients in Four Canadian Cities
-
CHESS Health Partners with Ria Health to Bring 24/7 Peer-Backed Digital Recovery Support to Virtual Care
-
Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma
-
Ria Health Brings 24/7 Peer Support to Virtual Alcohol Treatment Through Partnership with CHESS Health
-
Lux Metals Reports 0.71% Cu over 19.50 m Within Previously Reported 17.57 g/t Au Intercept, including 1.45% Cu with 39.08 g/t Au over 8.00 m, Confirming Gold-Copper Mineralization at Zone 32, La Grand
-
Their Death Reminds Us to Drive Sober: MADD Canada’s Project Red Ribbon Campaign Calls on Canadians to Prevent Impaired Driving
-
Boralex accelerates expansion in the United Kingdom with the acquisition of Wind2
-
Talisker Intersects 301.88 g/t Au over 0.55 m within 79.23 g/t Au over 2.10 metres in the Bralorne West Zone - 2026 Bralorne Gold Project Resource Conversion Program
-
First Mid Bancshares, Inc. Announces Acquisition of Evergreen Bancshares, Inc.
-
Apollo Silver Delivers Positive PEA for Calico
-
Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial
-
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
-
Ligand Reports Third Quarter 2026 Financial Results
-
Radware to Participate in Upcoming Investor Conferences
-
Ocugen to Participate in Upcoming November Investor and Industry Conferences
-
First Mid Bancshares, Inc. Announces Third Quarter 2026 Results
-
MariMed Stockholders Approve Proposed Reverse Stock Split
-
First Northwest Bancorp Reports Third Quarter 2026 Financial Results
-
Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences
-
Americold Launches Global Innovation Center to Advance Technology, Operations and Customer Solutions
-
Broadwind Announces Third Quarter 2026 Results Conference Call and Webcast Date
-
Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals
-
Legence Sets Third Quarter 2026 Earnings Release Date and Webcast Schedule
-
Telesat reports results for the three and nine months ended September 30, 2026
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VESUVIUS PLC - Ordinary Shares
-
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations
-
LKQ Corporation Announces Results For Third Quarter 2026
-
Bites Raises $40M Series A to Turn Frontline Training into a Business Performance Engine
-
Tilray Brands Announces Next Phase of Beverage Transformation
-
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance
-
Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)
-
Amplify ETFs Declares October Income Distributions for its Income ETFs
-
Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
-
Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth
-
WSP selected as strategic delivery partner for American Electric Power
-
Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London
-
Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals
-
Flux Power Advances Battery Safety and Fleet Intelligence with Three New Innovations
-
HII Reports Third Quarter 2026 Results
-
C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders
-
Legence Sets Third Quarter 2026 Earnings Release Date and Webcast Schedule
-
Kobalt Labs Selected by Bangor Savings Bank to Streamline BaaS Risk and Compliance Management
-
Aeluma to Announce First Quarter Fiscal Year 2027 Financial Results on November 12, 2026


